Jaehyun Jo

Jaehyun Jo


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2026 in Bioengineering
Verified
Journal Article
Open access
PDF file
CCChoi MoonHyeok ChoiMoonHyeok
Choi MoonHyeok ChoiMoonHyeok
JJJaehyun Jo
Jaehyun Jo
JJJin-Hyoung Jeong
Jin-Hyoung Jeong
Parkinson’s disease (PD) is associated with progressive gait deterioration; however, widely used clinical scales such as the Hoehn & Yahr (H&Y) stage are limited in capturing continuous severity changes due to subjectivity and discrete grading. This study proposes a two-stage explainable AI framework using vertical ground reaction force (VGRF) signals to achieve reproducible PD detection and continuous severity estimation. In the first stage, three deep learning models, temporal convolutional network (TCN), BiGRU with attention, and FCNN-Transformer, were trained using windowed VGRF signals under repeated subject-wise data segmentation. All models achieved high discrimination performance (AUC ≥ 0.93), with FCNN-Transformer showing the highest mean AUC (0.940) and statistically superior performance (paired Wilcoxon test, p < 0.05). Stability-based explainable AI using Integrated Gradients consistently identified variability-related VGRF features as the most informative, which were also significantly different between groups at the data level (p < 0.001, FDR-corrected). In the second stage, XGBoost regression was applied to PD subjects to predict continuous H&Y severity, achieving strong correlation with clinical grades (Spearman ρ = 0.921, p < 0.001), low error (MAE = 0.158, RMSE = 0.241), and high determination (R2 = 0.953). This shows that gait-based features are a sensitive enough signal to continuously quantify disease progression. In addition, in the TREND prospective longitudinal cohort (n = 696), wearable walking indicators differed significantly from those of non-patients prior to diagnosis, and a decline in walking pace was observed approximately four years before Parkinson’s disease diagnosis, providing the basis for early screening and monitoring using gait-based digital biomarkers. These results demonstrate that gait-based digital biomarkers can objectively quantify both PD presence and disease progression. The proposed framework provides a reproducible, explainable, and clinically interpretable AI-based decision support approach for PD assessment.

1 October 2025 in Life
Verified
Journal Article
Open access
PDF file
YJYuyeon Jung
Yuyeon Jung
YPYeji Park
Yeji Park
JJJaehyun Jo
Jaehyun Jo
JJJin-Hyoung Jeong
Jin-Hyoung Jeong
Early and accurate diagnosis of dementia is essential to improving patient outcomes and reducing societal burden. The Mini-Mental State Examination (MMSE) is widely used to assess cognitive function, yet traditional statistical and machine learning approaches often face limitations in capturing nonlinear interactions and subtle decline patterns. This study developed a novel deep learning-based dementia prediction model using MMSE data collected from domestic clinical settings and compared its performance with traditional machine learning models. A notable strength of this work lies in its use of item-level MMSE features combined with explainable AI (SHAP analysis), enabling both high predictive accuracy and clinical interpretability—an advancement over prior approaches that primarily relied on total scores or linear modeling. Data from 164 participants, classified into cognitively normal, mild cognitive impairment (MCI), and dementia groups, were analyzed. Individual MMSE items and total scores were used as input features, and the dataset was divided into training and validation sets (8:2 split). A fully connected neural network with regularization techniques was constructed and evaluated alongside Random Forest and support vector machine (SVM) classifiers. Model performance was assessed using accuracy, F1-score, confusion matrices, and receiver operating characteristic (ROC) curves. The deep learning model achieved the highest performance (accuracy 0.90, F1-score 0.90), surpassing Random Forest (0.86) and SVM (0.82). SHAP analysis identified Q11 (immediate memory), Q12 (calculation), and Q17 (drawing shapes) as the most influential variables, aligning with clinical diagnostic practices. These findings suggest that deep learning not only enhances predictive accuracy but also offers interpretable insights aligned with clinical reasoning, underscoring its potential utility as a reliable tool for early dementia diagnosis. However, the study is limited by the use of data from a single clinical site with a relatively small sample size, which may restrict generalizability. Future research should validate the model using larger, multi-institutional, and multimodal datasets to strengthen clinical applicability and robustness.

10 March 2026 in Life
Verified
Journal Article
Open access
PDF file
CCChoi MoonHyeok ChoiMoonHyeok
Choi MoonHyeok ChoiMoonHyeok
JJJaehyun Jo
Jaehyun Jo
JJJin-Hyoung Jeong
Jin-Hyoung Jeong
The primary objective of this study was to evaluate the relative contributions of the MMSE and nWBV in three-class cognitive stage classification, with a secondary objective of conducting a subgroup analysis to investigate latent risk within the MMSE-normal population. To achieve this, we proposed an explainable deep-learning-based analytical framework integrating the MMSE with nWBV, a structural brain atrophy indicator, and systematically assessed the relative contributions of each variable in cognitive impairment stage classification and potential risk screening. Although the MMSE is widely used in clinical practice as a cognitive screening tool, it has limited sensitivity to early or subtle cognitive decline and may not adequately reflect structural brain changes due to the ceiling effect. To address this limitation, we compared four tabular deep learning models—MLP, Tab ResNet, Tab Transformer, and FT Transformer—under identical fivefold cross-validation conditions. Age and sex were fixed as covariates, and feature ablation analysis was conducted to examine the independent and combined effects of the MMSE and nWBV. The results showed no statistically significant differences in classification performance among model architectures, indicating that predictive performance was primarily determined by the informational content of the input variables rather than model complexity. In the feature ablation analysis, the MMSE alone demonstrated strong discriminative power, whereas nWBV alone showed relatively limited performance; however, when combined with the MMSE, nWBV consistently improved classification performance. Furthermore, for interpretability analysis, both Integrated Gradients (IG) and SHAP were applied to validate variable contributions from complementary perspectives. Across both methods, the MMSE and nWBV were repeatedly identified as key contributing features, and interpretability stability was maintained throughout cross-validation folds, supporting the robustness and reliability of the explanatory results. Beyond simple model performance comparisons, this study provides evidence supporting the complementary integration of structural brain atrophy information into MMSE-centered traditional cognitive assessment by jointly considering variable contribution and interpretability stability. This approach is expected to contribute to precision risk screening and clinical decision support in the early stages of cognitive decline. Although the MMSE exhibited strong discriminative performance, nWBV provided complementary structural risk signals within the MMSE-normal subgroup, suggesting that integrating cognitive assessment with structural biomarkers may enhance early risk identification.

14 January 2026 in Processes
Verified
Journal Article
Open access
PDF file
Dahae LeeDahae Lee
Dahae Lee
Kim JiyoolKim Jiyool
Kim Jiyool
JJJin-Hyoung Jeong
Jin-Hyoung Jeong
JJJaehyun Jo
Jaehyun Jo
Young-Tae ParkYoung-Tae Park
Young-Tae Park
Ki Sung  KangKi Sung Kang
Ki Sung Kang
The pharmacological effects of ginger extract from Zingiber officinale Roscoe are well-established; however, more refined extraction methods for higher-quality yields are needed. This study isolated and evaluated 6-, 8-, and 10-shogaol and 6-, 8-, and 10-gingerol from ginger extract, assessing their effects on glucose-stimulated insulin secretion (GSIS). To ensure safety, non-toxic concentrations were determined for pancreatic β-cells. Both non-processed and microwave-processed ginger extracts enhanced GSIS, with microwave-treated extracts exhibiting the strongest effect. Specifically, the microwave-processed ginger extract increased the glucose stimulation index (GSI) to 12.4 ± 0.4 at 5 μg/mL, compared to a GSI of 7.7 ± 0.2 observed for the non-processed ginger extract. Notably, fraction F4 of the microwave-processed extract demonstrated superior GSIS activity. In contrast, steam-processed ginger extract induced only a modest increase in GSI under limited exposure conditions. Furthermore, 6-shogaol emerged as a key compound, correlating with increased expression of proteins crucial for pancreatic β-cell regulation. Microwave-assisted processing notably altered the content and proportion of shogaols and gingerols, significantly impacting GSIS activity. These findings underscore the importance of extraction methods in enhancing ginger’s pharmacological potential in regulating insulin secretion and pancreatic β-cell function.

11 December 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
SLSangsik Lee
Sangsik Lee
JJJaehyun Jo
Jaehyun Jo
SBSo Hyeon Bang
So Hyeon Bang
JJJin-Hyoung Jeong
Jin-Hyoung Jeong
The purpose of this study was to develop a model capable of predicting stress levels and interpreting the underlying physiological patterns using large-scale, real-life biosignal data. To achieve this, we utilized approximately 137,000 longitudinal measurements voluntarily collected from residents of Sejong Special Self-Governing City over a two-year period (February 2023–December 2024). Based on these data, we constructed a stress prediction framework that integrates both static machine-learning models—such as Random Forest and LightGBM—and time-series deep learning models, including LSTM and Transformer architectures. Model interpretability was further enhanced through SHapley Additive exPlanations (SHAP), which quantified the contribution of key biomarkers, and through visualization of Transformer attention weights to reveal temporal interactions within the biosignal sequences. The central objective of this study was to evaluate how accurately a deep learning model can learn and reproduce stress indices generated by existing heart rate variability (HRV)-based algorithms embedded in K-FDA-approved wearable devices. Accordingly, the ground truth used in this work reflects algorithmic outputs rather than clinically validated assessments such as salivary cortisol or psychological scales. Thus, rather than identifying independent clinical stress markers, the present work focuses on determining whether a Transformer-based model can effectively approximate device-derived physiological stress levels over time, thereby providing a methodological foundation for future applications using clinically validated stress labels. Experimental results demonstrated that the Transformer model achieved approximately 98% classification accuracy across this large dataset, indicating that it successfully captures short-term biosignal fluctuations as well as long-term temporal structure. These findings collectively demonstrate the engineering feasibility of developing a large-scale, wearable-based stress monitoring system.

25 February 2026 in Processes
Verified
Journal Article
Open access
PDF file
YJYoungsic Jeon
Youngsic Jeon
HKHyukjoon Kwon
Hyukjoon Kwon
HKHyeonseok Ko
Hyeonseok Ko
GHGyuwon Huh
Gyuwon Huh
SYSolmin Yong
Solmin Yong
Young-Joo KimYoung-Joo Kim
Young-Joo Kim
Socheongryong-tang (SCRT), traditionally used in East Asia for managing chills and fever, has recently gained attention for its immunomodulatory potential. This study aimed to elucidate the biological activity and signaling features associated with SCRT-mediated modulation of innate immune readouts in murine macrophages and to evaluate its effects on selected markers in a 5-fluorouracil (5-FU)-associated immune suppression model. Our findings reveal that SCRT significantly enhances phagocytic activity, production of nitric oxide and prostaglandin E2, and the mRNA expression of cytokines, including tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6. These immunomodulatory effects are associated with activation of the reactive oxygen species/mitogen-activated protein kinases/nuclear factor-κB signaling axis. In vivo, SCRT administration in a 5-FU–treated mouse model attenuated immune suppression-associated changes, showing partial restoration of selected serum cytokine markers and immune response indices. Taken together, these results suggest that SCRT aqueous extract may attenuate chemotherapy-associated immune dysfunction; however, further studies incorporating immune cell profiling, functional immune assessments, and pathway- and contamination-control approaches are warranted to establish causality and translational relevance.